Biokin Pharmaceutical selects Cryoport

business deal concept

Biokin Pharmaceutical Co. Ltd. has selected Cryoport’s full suite of temperature-controlled solutions to support its Phase I and II clinical trials in immuno-oncology in both the US and China.

You must be a subsciber to read this content

If you already subscribe, please sign-in now

Subscribe to Gas World

 

Get instant access to must-read content from top industry writers!

To access hundreds of features, subscribe today! Discover the in-depth content our subscribers receive every month by reading this week’s free feature. Join gasworld and become a subscriber to access all of our content online from just $270.